About
Acceptance rate
9%Time to first decision with review
47 days*Time from acceptance to publication
17 days*Impact Factor (JCR)
13.654Citescore
15.12021 total content views
3,112,388Aims and scope
Journal of Neurology, Neurosurgery & Psychiatry (JNNP)’s ambition is to publish the most ground-breaking and cutting-edge research from around the world. Encompassing the entire genre of neurological sciences, our focus is on the common disorders (stroke, multiple sclerosis, Parkinson’s disease, epilepsy, peripheral neuropathy, subarachnoid haemorrhage and neuropsychiatry), but with a keen interest in the Gordian knots that present themselves in the field, such as ALS. With early online publication, regular podcasts and an immense archive collection (with the longest half-life of any journal in clinical neuroscience), JNNP is a trail-blazer and not a follower. Subscribers to JNNP also have access to Practical Neurology and the Journal of NeuroInterventional Surgery.
JNNP is the flagship of BMJ’s neurology and neuroscience portfolio and has an open access companion journal, BMJ Neurology Open.
For information about the Editor-in-Chief and editorial team, please refer to the Editorial Board page.
Plan S compliance
Journal of Neurology, Neurosurgery & Psychiatry is a Plan S compliant Transformative Journal. Transformative Journals are one of the compliance routes offered by cOAlition S funders, such as Wellcome, WHO and UKRI. Find out more about Transformative Journals and Plan S compliance on our Author Hub.
Editions
Practical Neurology
Practical Neurology is a bi-monthly educational supplement, free to JNNP subscribers. Each issue of Practical Neurology publishes reviews and essays from eminent neurologists from around the world, as well as educational material to test your knowledge. Papers are rigorously edited to present the working neurologist with accessible, engaging, up-to-date information.
Journal information
| Ownership | JNNP is owned by BMJ |
|---|---|
| Publication Model | Subscription; with hybrid open access option |
| Frequency | Â 12 issues per year |
| Launch date | Â 1920 |
| Digital Archives | Portico, LOCKSS |
| Indexed by | Web of Science Core Collection: Science Citation Index, Science Citation Index Extended; BIOSIS Previews, Current Contents: Clinical Medicine, Life Sciences, MEDLINE (Index Medicus), PubMed Central (BMJ Open Access Special Collection), Scopus, Embase (Excerpta Medica), CINAHL, Google Scholar |
| Peer Review Model | Single blind; the names of reviewers are hidden from the author |
| Print ISSN | 0022-3050 |
| Online ISSN | 1468-330X |
Journal Statistics (2021)
Acceptance rate: 9%
Speed
Time to first decision with review: 47 days (median)
Time to first decision without review: 4 days (median)
Time from acceptance to publication: 17 days (median)
Impact
Impact Factor category: Clinical Neurology
Impact factor (JCR): 13.654
Impact Factor rank: 7/212
5 year Impact Factor: 12.013
Journal Citation Indicator (JCI): 2.64
Eigenfactor Score: 0.02508
Citescore: 15.1
Citescore rank: 11/359
Scimago Journal rank (SJR): 2.922
Reach
2021 total content views: 3,112,388
2021 total Altmetric mentions: 11,762
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure.
Contact information
For all contact information please refer to the Contact Us page.
For authors
Please refer to the Instructions for Authors
Subscriptions
To advertise
Rights and permissions
Affiliations
The BMJ Publishing Group is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. The BMJ Group is a sponsor of its activities.
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.